This led to a flurry by all the major pharmaceutical companies who counted the US as their major market to rapidly increase their imports and stockpile inventory inside the US as insurance against the unknown costs of the tariffs. Ireland’s pharma exports rocketed in the process, almost doubling month on month through the year, reaching €90.4bn in the year to October. Major investments in US announcedThis led a number of large pharma companies, hoping to gain favour with the Trump administration, to announce major investments in the US. While some commitments don’t include a timeline, most companies made pledges spanning the remaining three years of the Trump administration. The UK trade off that the country’s public health service NHS will pay manufacturers more for their drugs, opens the door for the EU to offer the Trump administration a similar deal.

Source: Irish Examiner January 04, 2026 16:05 UTC